Page 19 - Blog Posts News Today

/PRNewswire/ -- The Bronchiectasis drugs market has been growing at a rapid pace over the years because of factors such as the high presence of Bronchiectasis...

On February 8, 2021, the New York Privacy Act (the "Act" or "NY Privacy Act") was approved by the New York Senate Consumer Protection Committee.

/PRNewswire/ -- The expected launch of potential therapies such as Abrocitinib/ PF-04965842, ARQ-151 (Roflumilast cream), Lebrikizumab (LY3650150), Etrasimod...

/PRNewswire/ -- The potential therapies such as OPC-61815, Omecamtiv mecarbil, Furoscix infusor, Revascor (Rexlemestrocel-L), CardiAMP cell therapy,...

/PRNewswire/ -- New explorative therapies such as parsaclisib (Incyte Corporation), zandelisib (ME-401) (MEI Pharma), Breyanzi (Bristol Myers), Betalutin...

In January 2022, many businesses operating loyalty programs in the State of California received notices for allegedly violating the California Consumer Privacy Act ("CCPA").

/PRNewswire/ -- New explorative therapies such as parsaclisib (Incyte Corporation), zandelisib (ME-401) (MEI Pharma), Breyanzi (Bristol Myers), Betalutin...

As the clock ticks closer to January 1, 2023, businesses need to, among other measures, update their privacy policies to comply with the California Privacy Rights Act.

The Hedgehog Review is published three times per year by the Institute for Advanced Studies in Culture. In keeping with the Institute’s own mission and vision, the journal is concerned with issues of contemporary cultural change and its individual and social consequences.

(Chuck Muth) – OK, I conducted my first one-day Campaign Boot Camp at the Ahern Corporate Headquarters in Las Vegas on January 15. Since then, I’ve gotten a number of requests from folks who missed it asking if I’d “do it again.”  So, tentatively pencil in… Saturday, March 5 in Norwalk, CT Saturday, March 12 in Las […]